ClinicalTrials.gov
ClinicalTrials.gov Menu

Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01663116
Recruitment Status : Completed
First Posted : August 13, 2012
Last Update Posted : March 6, 2013
Sponsor:
Information provided by (Responsible Party):
Cellerix ( TiGenix S.A.U. )